Ikarian Capital, LLC
- SEC CIK
- 0001778253
- Latest filing
- Aug 14, 2026
STOK holding history
Stoke Therapeutics, Inc. in every 13F filed by Ikarian Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
STOK overviewAll 13F holders of STOKFull Q2 2026 holdings
- Shares (Q1 2025)
- 0
- Sold out in Q1 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q2 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 0 | $0 | 0.0% | −6,798−100.0% | Sold out | Holders |
| Q4 2024 | 6,798 | $75.0K | <0.1% | −18−0.3% | Reduced | Holders |
| Q3 2024 | 6,816 | $83.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 6,816 | $92.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 6,816 | $92.0K | <0.1% | −5,300−43.7% | Reduced | Holders |
| Q4 2023 | 12,116 | $63.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 12,116 | $47.7K | <0.1% | −58,274−82.8% | Reduced | Holders |
| Q2 2023 | 70,390 | $748.2K | 0.3% | +70,390 | New | Holders |